What is PT-141?
PT-141 (Bremelanotide) is a synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH) that acts on melanocortin receptors in the brain to directly stimulate sexual desire. Unlike PDE5 inhibitors (Viagra, Cialis) which work on blood flow, PT-141 works centrally on the nervous system to increase libido in both men and women. It is FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women.
Mechanism of Action
PT-141 activates melanocortin receptors MC3R and MC4R in the hypothalamus, directly stimulating sexual arousal pathways. It increases dopamine release in the mesolimbic system, activates the paraventricular nucleus (the brain's sexual control center), and has been shown to produce erections in men with erectile dysfunction who don't respond to Viagra.
PT-141 Dosing Protocol
1–2 mg subcutaneous injection 45–60 minutes before sexual activity. Start at 0.5–1 mg to assess tolerance. Maximum: 2 mg per dose. Not for daily use — use as needed. Intranasal: 7.5–10 mg (less bioavailable).
Want a personalized protocol? Tell PepBot your goals, health status, and experience level for a custom PT-141 protocol.
PT-141 Benefits
Side Effect Profile
Nausea (most common, especially at higher doses), flushing, headache, transient blood pressure increase. Hyperpigmentation with frequent use. Start low to minimize nausea.
PT-141 Stacking Guide
PT-141 works synergistically with these compounds. Click any to learn more, or ask PepBot to build you a complete stack.
Research & Citations
Frequently Asked Questions about PT-141
Does PT-141 work for men?
How long does PT-141 last?
Still have questions about PT-141?
PepBot has encyclopedic knowledge of PT-141 — dosing, stacking, interactions, latest research, and personalized protocols. Ask anything.